ETrade Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

ETrade Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$484K	Buy	+9,941	New	+$418K	0.01%	565

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

ETrade Capital Management's ADPT Position: Q3 2020 in Review

ETrade Capital Management opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2020: 9,941 shares worth $484K. The stake represents 0.01% of the portfolio and ranks #565 among its holdings.

206 funds tracked by Wall St. Rank hold ADPT as of Q3 2020.

ETrade Capital Management held 9,941 shares of Adaptive Biotechnologies worth $484K as of Q3 2020.
Adaptive Biotechnologies was a new ETrade Capital Management position in Q3 2020.
Adaptive Biotechnologies made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #565 holding.
206 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.